2026-2027 Amyloidosis Fellowship Program
Oct 31, 2025
The International Society of Amyloidosis (ISA) is pleased to announce that applications are now open for the 2026-2027 Amyloidosis Fellowship Program.
This expanded program supports clinical training in all types of amyloidosis and aims to develop future leaders in diagnosis, management, and research—especially in ATTR and AL amyloidosis.
Fellowship applicants should hold an MD degree or equivalent. Preference will be given to those who have completed or are about to complete a relevant fellowship (cardiology, hematology, neurology, etc.). Some clinical experience, especially with amyloidosis, is preferred.
The host institution’s amyloidosis center or program must have specialists (e.g. at a minimum cardiologists, hematologists) with expertise in diagnosing and treating amyloidosis. Expertise in at least two additional disciplines from the following list is desirable: neurology, pathology, nephrology, radiology, and organ transplantation. The institution’s amyloidosis program should have a volume of patients such that a fellow would see a mix of types of amyloidosis and at least 15 patients with amyloidosis per week (new and follow-up on an outpatient basis).
Preference will be given to centers with a track record of clinical trials, research, and publications in the amyloidosis field. Ideally, the host institution will offer the fellow opportunities to participate in research programs.
Fellowships are awarded based on available funding and require a joint application from the fellow and host institution.
